A new study suggests that monkeys chronically infected with babesiosis, a tick-borne parasite, are able to suppress malaria infection when exposed to a simian malaria parasite. The researchers from the Biomedical Primate Research Center, Rijswijk, The Netherlands report their findings in the March 2010 issue of the journal Infection and Immunity.
Babesia parasites are known to infect a wide variety of mammalian hosts and awareness of the role these organisms play as zoonotic agents of human disease is growing. Of the population infected with Babesia microti, 25 percent of adults and 50 percent of children remain asymptomatic. Human malaria is caused by four different Plasmodium species, however, Plasmodium falciparum and Plasmodium vivax are the most significant with P. falciparum attributed to more than 1 million deaths annually in sub-Saharan Africa.
Prior studies of Babesia and Plasmodium co-infection in rodents have reported induced cross-protection. In an attempt to confirm their prior report that a rhesus macaque chronically infected with B. microti was able to suppress infection with Plasmodium cynomolgi (a parasite of macaques with attributes similar to P. vivax), researchers infected six naive monkeys with B. microti and then 24 days later challenged four of them plus four naïve monkeys with P. cynomolgi blood-stage parasites. Results showed a significant decrease in P. cynomolgi infection in monkeys coinfected with B. microti.
"We conclude that ongoing infection with B. microti parasites leads to suppression of malaria infection," say the researchers.
Reference: L.M. van Duivenvoorde, A. Voorberg-van der Wel, N.M. van der Werff, G. Braskamp, E.J. Remarque, I. Kondova, C.H.M. Kocken, A.W. Thomas. 2010. Suppression of Plasmodium cynomolgi in rhesus macaques by coinfection with Babesia microti. Infection and Immunity, 78. 3: 1032-1039.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.